GSK-6853

CAS No. 1910124-24-1

GSK-6853( GSK6853 )

Catalog No. M12992 CAS No. 1910124-24-1

A potent, highly selective and cell-active BRPF1 bromodomain inhibitor with TR-FRET pIC50 of 8.1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 30 In Stock
5MG 33 In Stock
10MG 62 In Stock
25MG 112 In Stock
50MG 184 In Stock
100MG 297 In Stock
200MG 421 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK-6853
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, highly selective and cell-active BRPF1 bromodomain inhibitor with TR-FRET pIC50 of 8.1.
  • Description
    A potent, highly selective and cell-active BRPF1 bromodomain inhibitor with TR-FRET pIC50 of 8.1; displays>1600-fold selectivity over others bromodomains (BRPF2/3, BRD4 BD1/BD2); displaces NanoLuc-tagged BRPF1 bromodomain from Halo-tagged histone H3.3 (IC50=20 nM) and disrupts chromatin binding in cell assays; demonstrates properties suitable for cellular and in vivo studies.
  • In Vitro
    ——
  • In Vivo
    The ip route of administration would be suitable for dosing GSK6853 in potential PK/PD models.
  • Synonyms
    GSK6853
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    BRPF1|BRPF2|BRPF3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1910124-24-1
  • Formula Weight
    409.4815
  • Molecular Formula
    C22H27N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 29 mg/mL
  • SMILES
    O=C(NC1=C(N2[C@H](C)CNCC2)C=C(N3C)C(N(C)C3=O)=C1)C4=CC=CC=C4OC
  • Chemical Name
    Benzamide, N-[2,3-dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-2-methoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bamborough P, et al. ACS Med Chem Lett. 2016 May 9;7(6):552-7.
molnova catalog
related products
  • BET-BAY 002

    BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.

  • BRD4 inhibitor Compo...

    BRD4 inhibitor Compound V is a domain-selective inhibitor of BRD4 with IC50 of 1.8 uM for BRD4 BD1, displays 6- and 16-fold selectivity for BRD4 over BRD2 and BRD3, respectively.

  • BAY 1238097

    BAY 1238097 is a novel BET bromodomain inhibitor with IC50 of 50 nM.